AA
TVGN icon

AQR Arbitrage’s Tevogen Bio Holdings TVGN Stock Holding History

AQR Arbitrage’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,905
Closed -$5.12M – 1076
2022
Q4 		$5.12M Hold
9,905
– – 0.13% 220
2022
Q3 		$5.03M Hold
9,905
– – 0.11% 249
2022
Q2 		$4.96M Hold
9,905
– – 0.11% 244
2022
Q1 		$4.95M Buy
+9,905
New +$4.93M 0.13% 185

Other funds holding TVGN

CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AQR Arbitrage's TVGN Position: Q1 2023 in Review

AQR Arbitrage sold out of Tevogen Bio Holdings (TVGN) in Q1 2023, closing a stake of 9,905 shares — an estimated $5.12M sold.

AQR Arbitrage first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $5.12M in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

  • AQR Arbitrage reported no remaining Tevogen Bio Holdings position as of Q1 2023 after selling out during the quarter.
  • AQR Arbitrage sold 9,905 Tevogen Bio Holdings shares in Q1 2023, an estimated $5.12M.
  • AQR Arbitrage first reported a position in Tevogen Bio Holdings in Q1 2022 and held it in 4 quarters.
  • AQR Arbitrage's Tevogen Bio Holdings position peaked at $5.12M in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2023.

Based on AQR Arbitrage's 13F filing for Q1 2023, filed 15 May 2023.